0000014272-17-000206.txt : 20171213 0000014272-17-000206.hdr.sgml : 20171213 20171213173102 ACCESSION NUMBER: 0000014272-17-000206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171212 FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Thomas J. Jr. CENTRAL INDEX KEY: 0001474056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 171254697 MAIL ADDRESS: STREET 1: 800 HOWARD AVENUE STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 wf-form4_151320424860165.xml FORM 4 X0306 4 2017-12-12 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001474056 Lynch Thomas J. Jr. BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 EVP & Chief Scientific Officer Common Stock, $0.10 par value 2017-12-12 4 S 0 5300 63.24 D 9250.964 D These shares were sold to cover taxes in connection with the settlement of Deferred Share Units. Deferred Share Units convert into a share of common stock upon settlement. /s/ Katherine Kelly, attorney-in-fact for Thomas J. Lynch, Jr. M.D. 2017-12-13